Jeffrey Raber (Presenter)
The Werc Shop
Bio: Dr. Raber received his B.S. in biochemistry from Lebanon Valley College, PA and subsequently a Ph.D. in organic chemistry from the University of Southern California with an emphasis on developing new synthetic methodologies useful in pharmaceutical drug discovery and manufacturing efforts. Dr. Raber founded The Werc Shop in 2010 with a focus on botanical analysis, new product developments and sustainability. The Werc Shop’s first goal was addressing unmet public health and safety needs within the medical cannabis community. Dr. Raber’s detailed investigations into the chemistry of cannabis, including 5 peer reviewed publications, provide him with a unique perspective and knowledge base useful in assisting state and local regulators in the construction and implementation of effective regulatory solutions for the safe and sustainable delivery of medical cannabis to qualified patients.
Authorship: Jeffrey C. Raber, Ph.D.
The Werc Shop, LLC
| Short Abstract Cannabis sativa L. is an exceptionally diverse plant rapidly rising in acceptance as a physiologically useful tool for alleviating numerous chronic ailments. The use of whole-plant cannabis products often offers greater therapeutic effectiveness than single molecule cannabinoid approaches. This presents unique challenges in determining product chemical compositions required for entering the clinic. Furthermore, metabolic profiling of these compositions can be exceptionally complex and require the development of advanced analytical methodologies to provide useful clinical insight. As new laws and regulations around cannabis continue to develop we will undoubtedly see many diverse whole-plant products begin to enter the clinic. |
Long Abstract
Cannabis sativa L. is an exceptionally diverse plant rapidly rising in acceptance as a physiologically useful tool for alleviating numerous chronic ailments. The use of whole-plant cannabis products often offers greater therapeutic effectiveness than single molecule cannabinoid approaches. This presents unique challenges in determining product chemical compositions required for entering the clinic. Furthermore, metabolic profiling of these compositions can be exceptionally complex and require the development of advanced analytical methodologies to provide useful clinical insight. As new laws and regulations around cannabis continue to develop we will undoubtedly see many diverse whole-plant products begin to enter the clinic.
References & Acknowledgements:
| Description | Y/N | Source |
| Grants | no | |
| Salary | yes | The Werc Shop |
| Board Member | yes | The Werc Shop |
| Stock | yes | The Werc Shop |
| Expenses | no |
IP Royalty: no
| Planning to mention or discuss specific products or technology of the company(ies) listed above: | yes |